To Evaluate the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold (Wind-cold Syndrome) in a Multicenter, Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Trial
Status: Recruiting
Location: See all (24) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
To further evaluate the efficacy and safety of Antiwei granule in the treatment of common cold (wind-cold syndrome)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• It met the diagnostic criteria of common cold in western medicine;
• In accordance with the TCM syndrome differentiation standard of wind-cold syndrome;
• Male and female patients aged 18 to 65 years;
• The disease duration at enrollment was ≤48 h;
• At enrollment, 37.3 ° C ≤axillary temperature \< 38.5 ° C;
• Informed consent was obtained voluntarily.
Locations
Other Locations
China
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
RECRUITING
Beijing
changsha Hospital Affiliated to Hunan University
RECRUITING
Changsha
Chengdu Pidu District Hospital of TCM
RECRUITING
Chengdu
Heilongiang Provincial Traditional Chinese Medicine Hospital
RECRUITING
Haerbin
The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
RECRUITING
Haerbin
Huizhou Third People's Hospital
RECRUITING
Huizhou
Kaifeng Hospital of Traditional Chinese Medicine
RECRUITING
Kaifeng
Luoyang Third People's Hospital
RECRUITING
Luoyang
The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University
RECRUITING
Luzhou
The Affiliated Hospital of Jiangxi Uniwersity of TCM
RECRUITING
Nanchang
Panjin Liaoyou Baoshihua Hospital
RECRUITING
Panjin
Quzhou People's Hospital
RECRUITING
Quzhou
Sanmenxia Central Hospital
RECRUITING
Sanmenxia
Longhua Hospital, Shanghai University of Traditional Chinese Medicine,
RECRUITING
Shanghai
Shangqiu First People's Hospital
RECRUITING
Shangqiu
The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medcine
RECRUITING
Shenyang
Hebei Provincial Hospital of Traditional Chinese Medicine
RECRUITING
Shijiazhuang
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
RECRUITING
Tianjin
Tonghua Central Hospital
RECRUITING
Tongzhou
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
RECRUITING
Xi'an
Xidian Group Hospital
RECRUITING
Xi'an
The Second Affiliated Hospital of Xingtai Higher Medical College
RECRUITING
Xingtai
Yangquan Coal Industry(Group) General Hospital
RECRUITING
Yangquan
Henan Provincial People's Hospital
RECRUITING
Zhengzhou
Contact Information
Primary
Rui Liu
liurui2@tasly.com
022-86343726
Time Frame
Start Date: 2023-11-16
Estimated Completion Date: 2025-07-01
Participants
Target number of participants: 480
Treatments
Experimental: Antaiwei granules
Placebo_comparator: Antaiwei granules placebo
Related Therapeutic Areas
Sponsors
Leads: Tasly Pharmaceutical Group Co., Ltd